Crossmark

Cost–utility analysis of treatment strategies for chronic constipation in Japan

Published Online: 2025-10-30

Published Print: 2026-01

Authors

Hojo, Mariko

Igarashi, Ataru

Shoji, Ayako

Nagahara, Akihito https://orcid.org/0000-0001-5979-4384
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

Received: 18 March 2025

Accepted: 10 September 2025

First Online: 30 October 2025

Change Date: 14 November 2025

Change Type: Update

Change Details: This article has been updated to amend the missing institution name in affiliation 3 and missing equal contribution text.

Declarations

:

: Mariko Hojo reports honorarium from Viatris Pharmaceuticals Japan Inc. and is affiliated with an endowed course supported by Yakult Honsha Co., Ltd. Ataru Igarashi reports honoraria from EA Pharma Co., Ltd, and Astellas Pharma Inc. Ayako Shoji reports consulting fees from Healthcare Consulting Inc. Akihito Nagahara reports honoraria from Astellas Pharma Inc., EA Pharma Co., Ltd, Tsumura & Co., and Viatris Pharmaceuticals Japan Inc., and is affiliated with an endowed course supported by Yakult Honsha Co., Ltd.

Document is current